Departments of1Neurosurgery.
2Neurology, and.
J Neurosurg. 2018 Sep;129(3):658-669. doi: 10.3171/2017.4.JNS17557. Epub 2017 Oct 13.
OBJECTIVE It has been suggested that increased body mass index (BMI) may confer a protective effect on patients who suffer from aneurysmal subarachnoid hemorrhage (aSAH). Whether the modality of aneurysm occlusion influences the effect of BMI on patient outcomes is not well understood. The authors aimed to compare the effect of BMI on outcomes for patients with aSAH treated with surgical clipping versus endovascular coiling. METHODS The authors retrospectively reviewed the outcomes for patients admitted to their institution for the management of aSAH treated with either clipping or coiling. BMI at the time of admission was recorded and used to assign patients to a group according to low or high BMI. Cutoff values for BMI were determined by classification and regression tree analysis. Predictors of poor functional outcome (defined as modified Rankin Scale score > 2 measured ≥ 90 days after the ictus) and posttreatment cerebral hypodensities detected during admission were then determined separately for patients treated with clipping or coiling using stepwise multivariate logistic regression analysis. RESULTS Of the 469 patients admitted to the authors' institution with aSAH who met the study's inclusion criteria, 144 were treated with clipping and 325 were treated with coiling. In the clipping group, the frequency of poor functional outcome was higher in patients with BMI ≥ 32.3 kg/m (47.6% vs 19.0%; p = 0.007). In contrast, in the coiling group, patients with BMI ≥ 32.3 kg/m had a lower frequency of poor functional outcome at ≥ 90 days (5.8% vs 30.9%; p < 0.001). On multivariate analysis, high BMI was independently associated with an increased (OR 3.92, 95% CI 1.20-13.41; p = 0.024) and decreased (OR 0.13, 95% CI 0.03-0.40; p < 0.001) likelihood of poor functional outcome for patients treated with clipping and coiling, respectively. For patients in the surgical group, BMI ≥ 28.4 kg/m was independently associated with incidence of cerebral hypodensities during admission (OR 2.44, 95% CI 1.16-5.25; p = 0.018) on multivariate analysis. For patients treated with coiling, BMI ≥ 33.2 kg/m was independently associated with reduced odds of hypodensities (OR 0.45, 95% CI 0.21-0.89; p = 0.021). CONCLUSIONS The results of this study suggest that BMI may differentially affect functional outcomes after aSAH, depending on treatment modality. These findings may aid in treatment selection for patients with aSAH.
有人认为,体重指数(BMI)升高可能对患有蛛网膜下腔出血(aSAH)的患者起到保护作用。但是否动脉瘤闭塞方式会影响 BMI 对患者预后的影响尚不清楚。作者旨在比较 BMI 对接受夹闭术和血管内栓塞术治疗的 aSAH 患者结局的影响。
作者回顾性分析了在其机构接受夹闭术或血管内栓塞术治疗的 aSAH 患者的结局。记录患者入院时的 BMI,并根据 BMI 低值或高值将患者分为两组。通过分类回归树分析确定 BMI 的截断值。然后,使用逐步多元逻辑回归分析分别确定夹闭组和栓塞组患者治疗后 90 天改良 Rankin 量表评分>2(定义为预后不良)和入院期间发现的脑密度降低的预测因素。
在符合研究纳入标准的 469 名患有 aSAH 并入住作者机构的患者中,144 名接受夹闭术治疗,325 名接受血管内栓塞术治疗。在夹闭组中,BMI≥32.3kg/m2 的患者预后不良的发生率更高(47.6% vs. 19.0%;p=0.007)。相比之下,在栓塞组中,BMI≥32.3kg/m2 的患者预后不良的发生率更低(5.8% vs. 30.9%;p<0.001)。多变量分析显示,高 BMI 与夹闭和栓塞治疗患者预后不良的风险增加(OR 3.92,95%CI 1.20-13.41;p=0.024)和降低(OR 0.13,95%CI 0.03-0.40;p<0.001)独立相关。对于手术组的患者,BMI≥28.4kg/m2 与入院期间脑密度降低的发生率独立相关(OR 2.44,95%CI 1.16-5.25;p=0.018)。对于接受血管内栓塞术治疗的患者,BMI≥33.2kg/m2 与脑密度降低的可能性降低相关(OR 0.45,95%CI 0.21-0.89;p=0.021)。
这项研究的结果表明,BMI 可能会根据治疗方式的不同而对 aSAH 后的功能结局产生不同的影响。这些发现可能有助于 aSAH 患者的治疗选择。